Clinical Trial Update: Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World

View source ↗

Summary

A real-world clinical trial update reports on the safety and efficacy of avapritinib in Chinese patients with gastrointestinal stromal tumor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• AYVAKIT (avapritinib)

Snippet

Sponsor: CStone Pharmaceuticals | Conditions: Gastrointestinal Stromal Tumors | Status: COMPLETED